HealthDay News — For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study published online Sept. 23 in JAMA Network Open.
Brody H. Foy, DPhil, from Massachusetts General Hospital in Boston, and colleagues examined the association between mortality risk and elevated RDW at hospital admission and during hospitalization in 1641 patients with COVID-19 admitted to 1 of 4 hospitals.
The researchers found that among patients of all ages, elevated RDW (>14.5%) was associated with increased mortality risk. For the entire cohort, the relative risk (RR) was 2.73, with a mortality rate of 11% and 31% for those with normal and elevated RDW, respectively. The RRs were 5.25 for patients younger than 50 years, 2.90 for those aged 50 to 59 years, 3.96 for those aged 60 to 69 years, 1.45 for those aged 70 to 79 years, and 1.59 for those aged 80 years and older. In models adjusted for age, D-dimer level, absolute lymphocyte count, and common comorbidities such as diabetes and hypertension, RDW was associated with mortality risk (hazard ratio, 1.09 per 0.5% RDW increase and 2.01 for an RDW >14.5% vs ≤14.5%). Mortality was higher for patients whose RDW increased during hospitalization compared with those whose RDW did not change.
“Such discoveries could point to new treatment strategies or identify better markers of disease severity,” a coauthor said in a statement.